HUP0102892A2 - Erősen tömörített szilárd gyógyszerkészletet tartalmazó hatóanyag-leadó rendszer, eljárás az előállítására és alkalmazására - Google Patents

Erősen tömörített szilárd gyógyszerkészletet tartalmazó hatóanyag-leadó rendszer, eljárás az előállítására és alkalmazására

Info

Publication number
HUP0102892A2
HUP0102892A2 HU0102892A HUP0102892A HUP0102892A2 HU P0102892 A2 HUP0102892 A2 HU P0102892A2 HU 0102892 A HU0102892 A HU 0102892A HU P0102892 A HUP0102892 A HU P0102892A HU P0102892 A2 HUP0102892 A2 HU P0102892A2
Authority
HU
Hungary
Prior art keywords
delivery system
active ingredient
subject
preparation
drug delivery
Prior art date
Application number
HU0102892A
Other languages
English (en)
Inventor
Wolfgang Fleischer
Karen Reimer
Original Assignee
Euroceltique S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Euroceltique S.A. filed Critical Euroceltique S.A.
Publication of HUP0102892A2 publication Critical patent/HUP0102892A2/hu
Publication of HUP0102892A3 publication Critical patent/HUP0102892A3/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/04—Drugs for disorders of the respiratory system for throat disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Abstract

A találmány tárgya egy hatóanyag-leadó rendszer, amely egy alapvetőenizotróp szilárd halmazállapottal rendelkező, hatóanyagot tartalmazó,erősen tömörített gyógyszerkészletet tartalmaz, amely a hatóanyagottartalmazó belélegezhető részecskék létrehozására alkalmas, ahol azerősen tömörített szilárd gyógyszerkészlet legalább egy hatóanyagotliposzómákkal vagy egy hasonló szemcsés hordozóval asszociáltantartalmaz. A találmány tárgya továbbá egy eljárás a találmány szerintihatóanyag-leadó rendszer erősen tömörített szilárdgyógyszerkészletének előállítására, amely során a liposzómákat ismertmódon állítják elő vagy töltik meg, adott esetben legalább egysegédanyaggal keverik, majd ezt követően izosztatikus sajtolássalformatestté alakítják. Szintén a találmány tárgyát képezi egy erősentömörített szilárd gyógyszerkészlet alkalmazása a találmány szerintihatóanyag-leadó rendszerben olyan részecskék létrehozására, amelyekátfúvással és/vagy belégzéssel adagolhatók a légúti betegségek ésrendellenességek, valamint szervek betegségeinek ésrendellenességeinek terápiájában, génterápiában és/vagy immunizálásesetében. Ó
HU0102892A 1998-05-27 1999-05-27 Drug delivery system comprising a tightly compacted solid medicament stock, process for its preparation and for its use HUP0102892A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8689598P 1998-05-27 1998-05-27
PCT/EP1999/003680 WO1999061003A1 (en) 1998-05-27 1999-05-27 Drug delivery system comprising a tightly compacted solid medicament stock

Publications (2)

Publication Number Publication Date
HUP0102892A2 true HUP0102892A2 (hu) 2002-03-28
HUP0102892A3 HUP0102892A3 (en) 2002-12-28

Family

ID=22201600

Family Applications (3)

Application Number Title Priority Date Filing Date
HU0102337A HU226710B1 (en) 1998-05-27 1999-05-27 Preparations for the application of anti-inflammatory, especially antiseptic agents and/or agents promoting the healing of wounds, to the upper respiratory tract and/or the ear
HU0102899A HU226729B1 (en) 1998-05-27 1999-05-27 Preparation for the application of antiseptic agents and/or agents promoting the healing of wounds to the lower respiratory tract
HU0102892A HUP0102892A3 (en) 1998-05-27 1999-05-27 Drug delivery system comprising a tightly compacted solid medicament stock, process for its preparation and for its use

Family Applications Before (2)

Application Number Title Priority Date Filing Date
HU0102337A HU226710B1 (en) 1998-05-27 1999-05-27 Preparations for the application of anti-inflammatory, especially antiseptic agents and/or agents promoting the healing of wounds, to the upper respiratory tract and/or the ear
HU0102899A HU226729B1 (en) 1998-05-27 1999-05-27 Preparation for the application of antiseptic agents and/or agents promoting the healing of wounds to the lower respiratory tract

Country Status (19)

Country Link
US (2) US20080038330A1 (hu)
EP (3) EP1079807B1 (hu)
JP (3) JP4741726B2 (hu)
KR (3) KR20010043820A (hu)
CN (3) CN1303276A (hu)
AT (3) ATE235895T1 (hu)
AU (3) AU759264B2 (hu)
BR (3) BR9911070A (hu)
CA (3) CA2332389C (hu)
CY (1) CY1105834T1 (hu)
DE (6) DE29923848U1 (hu)
DK (2) DK1079806T3 (hu)
ES (2) ES2260915T3 (hu)
HK (2) HK1035335A1 (hu)
HU (3) HU226710B1 (hu)
IL (4) IL139229A0 (hu)
PT (2) PT1079806E (hu)
RU (3) RU2202340C2 (hu)
WO (3) WO1999061003A1 (hu)

Families Citing this family (70)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7297344B1 (en) 1999-05-27 2007-11-20 Euro-Celtique, S.A. Preparations for the promotion of wound healing in the upper respiratory tract and/or ear
PT1502586E (pt) * 1999-05-27 2007-01-31 Euro Celtique Sa Utilização de anti-sépticos no fabrico de uma preparação farmacêutica para a prevenção ou o tratamento de processos inflamatórios no interior do corpo humano
PT1180017E (pt) 1999-05-27 2010-05-28 Euro Celtique Sa Preparações com povidona-iodo para o tratamento de feridas
US7300667B1 (en) 1999-05-27 2007-11-27 Euro-Celtique, S.A. Preparations for the application of anti-inflammatory, especially antiseptic agents and/or agents promoting the healing of wounds, to the lower respiratory tract
RS50407B (sr) * 2000-02-08 2009-12-31 Euro-Celtique S.A., Oralne formulacije opijatnog agonista otporne na mehaničke,termičke i/ili hemijske promene fizičkih osobina doznog oblika
US6989157B2 (en) * 2000-07-27 2006-01-24 Nucryst Pharmaceuticals Corp. Dry powders of metal-containing compounds
EP1343372A2 (en) 2000-12-21 2003-09-17 Nektar Therapeutics Pulmonary delivery of polyene antifungal agents
US20030055026A1 (en) 2001-04-17 2003-03-20 Dey L.P. Formoterol/steroid bronchodilating compositions and methods of use thereof
US6667344B2 (en) 2001-04-17 2003-12-23 Dey, L.P. Bronchodilating compositions and methods
DE10125731A1 (de) * 2001-05-17 2003-03-06 A I D Autoimmun Diagnostika Gm Darreichungsform von immunologischen Wirkstoffen
DE10141650C1 (de) 2001-08-24 2002-11-28 Lohmann Therapie Syst Lts Transdermales Therapeutisches System mit Fentanyl bzw. verwandten Substanzen
AU2003213402A1 (en) * 2002-03-18 2003-09-29 Yamanouchi Pharmaceutical Co., Ltd. Powdery medicinal compositions for inhalation and process for producing the same
US7718189B2 (en) 2002-10-29 2010-05-18 Transave, Inc. Sustained release of antiinfectives
JP4391948B2 (ja) * 2002-11-11 2009-12-24 興和株式会社 損傷皮膚修復用組成物
US20040133099A1 (en) 2002-12-18 2004-07-08 Dyer R. Kent Otologic nanotechnology
EP1449520A1 (en) * 2003-02-24 2004-08-25 Euro-Celtique S.A. Use of PVP-Iodine liposomes for treatment of herpes
EP1479379B1 (en) * 2003-05-19 2007-08-29 Euro-Celtique S.A. Dry liposomal PVP-iodine compositions
US8651113B2 (en) 2003-06-18 2014-02-18 Swr&D Inc. Magnetically responsive nanoparticle therapeutic constructs and methods of making and using
US7344491B1 (en) 2003-11-26 2008-03-18 Nanobiomagnetics, Inc. Method and apparatus for improving hearing
US7723311B2 (en) 2003-06-18 2010-05-25 Nanobiomagnetics, Inc. Delivery of bioactive substances to target cells
TWI359675B (en) 2003-07-10 2012-03-11 Dey L P Bronchodilating β-agonist compositions
US20050058673A1 (en) 2003-09-09 2005-03-17 3M Innovative Properties Company Antimicrobial compositions and methods
US9028852B2 (en) 2004-09-07 2015-05-12 3M Innovative Properties Company Cationic antiseptic compositions and methods of use
FR2878746B1 (fr) 2004-12-02 2007-02-23 Vetoquinol Sa Sa Nouvelle composition pharmaceutique utilisable dans le domaine des vaccins
BRPI0608690B8 (pt) 2005-03-10 2021-05-25 3M Innovative Properties Co uso de uma composição antimicrobiana
BRPI0608691A2 (pt) 2005-03-10 2010-12-07 3M Innovative Properties Co composição antimicrobiana, e, métodos para matar ou inativar microorganismos em tecido da mucosa de um mamìfero, para tratar uma lesão ou ferimento infectado, para descolonização de microorganismos, para proporcionar eficácia antimicrobiana residual sobre uma superfìcie e para tratar uma condição
ES2594368T3 (es) 2005-12-08 2016-12-19 Insmed Incorporated Composiciones a base de lípidos de antiinfecciosos para tratar infecciones pulmonares
DE102006011314A1 (de) 2006-03-11 2007-10-18 Peter Dr. Engels Kosmetische Zubereitungen mit einem Zusatz aus der Baobab-Pflanze
US20080057129A1 (en) * 2006-04-03 2008-03-06 Lerner E I Drug microparticles
RU2315593C1 (ru) * 2006-08-02 2008-01-27 Открытое Акционерное Общество Завод Экологической Техники И Экопитания "Диод" Липосомальная композиция антиоксидантов для ингаляций при заболеваниях легких и верхних дыхательных путей
US8071127B2 (en) 2006-10-24 2011-12-06 Aradigm Corporation Dual action, inhaled formulations providing both an immediate and sustained release profile
US8268347B1 (en) * 2006-10-24 2012-09-18 Aradigm Corporation Dual action, inhaled formulations providing both an immediate and sustained release profile
US8119156B2 (en) 2006-10-24 2012-02-21 Aradigm Corporation Dual action, inhaled formulations providing both an immediate and sustained release profile
JP5551442B2 (ja) 2006-10-27 2014-07-16 スリーエム イノベイティブ プロパティズ カンパニー 抗菌剤組成物
US20100196455A1 (en) 2007-05-04 2010-08-05 Transave, Inc. Compositions of Multicationic Drugs for Reducing Interactions with Polyanionic Biomolecules and Methods of Use Thereof
US9333214B2 (en) 2007-05-07 2016-05-10 Insmed Incorporated Method for treating pulmonary disorders with liposomal amikacin formulations
US9119783B2 (en) 2007-05-07 2015-09-01 Insmed Incorporated Method of treating pulmonary disorders with liposomal amikacin formulations
US9114081B2 (en) 2007-05-07 2015-08-25 Insmed Incorporated Methods of treating pulmonary disorders with liposomal amikacin formulations
EA017359B1 (ru) * 2007-11-23 2012-11-30 Фармалунденсис Аб Способ и композиция для достижения бронхиальной релаксации
WO2009085651A1 (en) 2007-12-20 2009-07-09 Nucryst Pharmaceuticals Corp. Metal carbonate particles for use in medicine and methods of making thereof
KR20100048751A (ko) * 2008-10-31 2010-05-11 주식회사 동성바이오레인 스프레이 가능한 캡슐화된 기능성 미립자 조성물과 그 제조방법
NL2002442C2 (nl) 2009-01-22 2010-07-26 Weezenbeek Specialties B V Van Werkwijze voor het verjongen van een bitumen bevattende samenstelling.
EP2226073A1 (en) 2009-03-02 2010-09-08 Euro-Celtique S.A. Topical pharmaceutical composition comprising an antiseptic and arginine for wound healing
US20110086084A1 (en) * 2009-10-13 2011-04-14 David William Koenig Active Agent Containing Polymer Network Delivery Composition and Articles Using the Same
WO2012091534A1 (ru) 2010-12-30 2012-07-05 Республиканское Государственное Предприятие "Научный Центр Противоинфекционных Препаратов" Комитета Промышленности Министерства Индустрии И Новых Технологий Республики Казахстан" Антибактериальный агент для лечения инфекционных заболеваний бактериальной природы
US9925251B2 (en) 2011-10-19 2018-03-27 President And Fellows Of Harvard College Treatments for Mycobacterium tuberculosis
KR101860485B1 (ko) * 2011-11-03 2018-07-02 (주)아모레퍼시픽 미세 유화 입자를 포함하는 미용 티슈, 그 제조방법 및 사용방법
JP6402097B2 (ja) * 2012-05-21 2018-10-10 インスメッド インコーポレイテッド 肺感染症を処置するためのシステム
US10124066B2 (en) 2012-11-29 2018-11-13 Insmed Incorporated Stabilized vancomycin formulations
RU2538433C1 (ru) * 2013-06-11 2015-01-10 Закрытое акционерное общество "ФИРН М" (ЗАО ФИРН М") Фармацевтическая композиция для профилактики и лечения инфекционно-воспалительных заболеваний различной этиологии путем оромукозного введения
EP3060198A4 (en) 2013-10-22 2017-06-28 Aradigm Corporation Inhaled surfactant-modified liposomal formulations providing both an immediate and sustained release profile
RU2550932C1 (ru) * 2014-03-18 2015-05-20 Александр Александрович Кролевец Способ получения нанокапсул цефалоспориновых антибиотиков в ксантановой камеди
CA2943201A1 (en) * 2014-04-08 2015-10-15 Aradigm Corporation Liposomes that form drug nanocrystals after freeze-thaw
US9532986B2 (en) 2014-04-08 2017-01-03 Aradigm Corporation Liposomal ciprofloxacin formulations with activity against non-tuberculous mycobacteria
US20160120806A1 (en) * 2014-04-08 2016-05-05 Aradigm Corporation Nanocrystals formed in a microenvironment
PT3142643T (pt) 2014-05-15 2019-10-28 Insmed Inc Métodos para o tratamento de infeções mico bacterianas pulmonares não tuberculares
AU2015292256B2 (en) 2014-07-23 2020-09-17 Firebrick Pharma Limited Treatment and prevention of the common cold using povidone-iodine
KR102086150B1 (ko) 2017-04-10 2020-03-06 부산대학교 산학협력단 하이드로겔화 되는 창상 치료용 파우더 조성물 및 이의 제조방법
FR3066115B1 (fr) 2017-05-10 2019-06-28 Universite de Bordeaux Comprimes de vecteurs d'acides nucleiques
KR101935250B1 (ko) * 2017-07-04 2019-01-04 김대황 요오드제 및 삼투성 미각제를 포함하는 눈, 구강용, 비강용 또는 흡입용 항바이러스 및 항균 조성물
WO2019009630A1 (ko) * 2017-07-04 2019-01-10 김대황 수용해성이 향상된 요오드제 및 염화나트륨을 포함하는 고체 조성물 및 이의 수용액을 포함하는 눈, 구강용, 비강용 또는 흡입용 항바이러스 및 항균 조성물
US20200289552A1 (en) * 2017-07-04 2020-09-17 Fluchem Ltd Solid composition comprising iodine agent and sodium chloride having improved water solubility, and antiviral and antimicrobial composition for eye, oral cavity, nasal cavity or inhalation containing aqueous solution thereof
KR102026805B1 (ko) 2017-12-12 2019-11-04 주식회사 크로파세 항염 화장료 조성물
EP3773505A4 (en) 2018-03-30 2021-12-22 Insmed Incorporated PROCESS FOR THE CONTINUOUS MANUFACTURING OF LIPOSOMAL MEDICINAL PRODUCTS
EP3781151A1 (en) * 2018-04-17 2021-02-24 Université de Caen Normandie Bambuterol for the treatment of alzheimer's disease
RU2730834C1 (ru) * 2020-01-17 2020-08-26 Александр Александрович Кролевец Способ получения нанокапсул тимола
WO2021201310A1 (ko) * 2020-03-30 2021-10-07 현대바이오사이언스 주식회사 비타민과 덱스판테놀이 봉입된 에토좀 조성물 및 이의 제조방법
CN111700883B (zh) * 2020-07-23 2021-04-06 深圳大佛药业股份有限公司 一种硫酸沙丁胺醇缓释型吸入制剂及其生产工艺
JP2022151438A (ja) * 2021-03-26 2022-10-07 均 石井 外耳炎と中耳炎と内耳炎の治療薬。
JP2022151426A (ja) * 2021-03-26 2022-10-07 均 石井 上気道炎治療薬。

Family Cites Families (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE615889A (hu) * 1952-04-15 1900-01-01
US4113857A (en) * 1977-05-16 1978-09-12 The Purdue Frederick Company Process for the preparation of iodophor compounds and methods for stabilizing iodophor pharmaceutical compositions containing the same
US4675009A (en) * 1977-11-07 1987-06-23 Lec Tec Corporation Drug dispensing device for transdermal delivery of medicaments
US4235871A (en) * 1978-02-24 1980-11-25 Papahadjopoulos Demetrios P Method of encapsulating biologically active materials in lipid vesicles
FR2536278A1 (fr) * 1982-11-18 1984-05-25 Dupont Michele Nouvelle composition therapeutique utile notamment pour la cicatrisation des plaies
US4704383A (en) * 1983-12-29 1987-11-03 The Research Foundation Of State University Of New York Non-antibacterial tetracycline compositions possessing anti-collagenolytic properties and methods of preparing and using same
FR2581542B1 (fr) * 1985-05-07 1988-02-19 Oreal Compositions topiques destinees au traitement de la peau a base de derives de l'acide salicylique
FR2591105B1 (fr) * 1985-12-11 1989-03-24 Moet Hennessy Rech Composition pharmaceutique, notamment dermatologique, ou cosmetique, a base de phases lamellaires lipidiques hydratees ou de liposomes contenant un retinoide ou un analogue structural dudit retinoide tel qu'un carotenoide.
SE8603812D0 (sv) * 1986-09-12 1986-09-12 Draco Ab Administration of liposomes to mammals
US5049388A (en) * 1986-11-06 1991-09-17 Research Development Foundation Small particle aerosol liposome and liposome-drug combinations for medical use
US4938965A (en) * 1987-07-22 1990-07-03 Her Majesty The Queen In Right Of Canada, As Represented By The Minister Of National Defence Of Her Majesty's Canadian Government Ocular delivery of prophylactic agents
US5246708A (en) * 1987-10-28 1993-09-21 Pro-Neuron, Inc. Methods for promoting wound healing with deoxyribonucleosides
DE3826946C1 (hu) * 1988-08-09 1990-03-15 A. Nattermann & Cie Gmbh, 5000 Koeln, De
US4906476A (en) * 1988-12-14 1990-03-06 Liposome Technology, Inc. Novel liposome composition for sustained release of steroidal drugs in lungs
US5006343A (en) * 1988-12-29 1991-04-09 Benson Bradley J Pulmonary administration of pharmaceutically active substances
US5232692A (en) * 1989-04-28 1993-08-03 Research And Education Institute, Inc. Povidone-iodine neonatal ophthalmic antimicrobial prophylactic agent
DK0407028T4 (da) * 1989-05-31 2000-01-31 Fisons Plc Anordning til inhalation af medikamenter og sammensætning af medikamenter
US5089389A (en) * 1989-08-25 1992-02-18 Eastman Kodak Company Buffered composition, coated article test device and a method for their use
US5128139A (en) * 1991-02-15 1992-07-07 Nu Skin International, Inc. Composition containing liposome-entrapped grapefruit seed extract and method for making
DE4111982C2 (de) * 1991-04-12 1998-12-24 Merz & Co Gmbh & Co Stabile kleinpartikuläre Liposomenzubereitungen, deren Herstellung und Verwendung
ATE159426T1 (de) * 1991-04-16 1997-11-15 Nippon Shinyaku Co Ltd Verfahren zur herstellung einer festen dispersion
ES2181673T3 (es) * 1991-05-01 2003-03-01 Jackson H M Found Military Med Procedimiento de tratamiento de las enfermedades respiratorias infecciosas.
AU4066693A (en) * 1992-12-23 1994-07-19 Bernhard Hugemann Compacted drug body for use in the mechanical generation of inhalable active-substance particles
US5552158A (en) * 1993-02-23 1996-09-03 Norac Technologies Inc. Skin care composition
DE4306475A1 (de) * 1993-03-02 1994-09-08 Ensenat Pedro Gonzalez Liposomen, enthaltend Chlorhexidindiacetat oder Chlorhexidindigluconat
WO1994028876A1 (en) * 1993-06-07 1994-12-22 Advanced Therapies, Inc. Liposome powders
US5512269A (en) * 1993-06-09 1996-04-30 Burroughs Wellcome, Co. Method of treating retained pulmonary secretions
US5456904A (en) * 1993-06-28 1995-10-10 The Procter & Gamble Company Photoprotection compositions comprising certain chelating agents
DE9312509U1 (de) * 1993-08-20 1993-10-28 Euro Celtique Sa Präparate zur äußeren Verabreichung von antiseptischen und/oder die Wundheilung fördernden Wirkstoffen
US5863556A (en) * 1993-08-20 1999-01-26 Euro-Celtique, S.A. Preparations for the external application of antiseptic agents and/or agents promoting the healing of wounds
WO1996014083A1 (de) * 1994-11-04 1996-05-17 Polymun Scientific Immunbiologische Forschung Gmbh Applikation von sod in liposomen
US5744457A (en) * 1995-03-31 1998-04-28 Hamilton Civic Hospitals Research Development Inc. Compositions and methods for inhibiting thrombogenesis
JPH08301774A (ja) * 1995-05-08 1996-11-19 Kowa Co 喉用殺菌消毒薬
AU7454698A (en) * 1997-06-06 1998-12-21 Shionogi & Co., Ltd. Improvement in medicament administration system
PT1180017E (pt) * 1999-05-27 2010-05-28 Euro Celtique Sa Preparações com povidona-iodo para o tratamento de feridas
US7297344B1 (en) * 1999-05-27 2007-11-20 Euro-Celtique, S.A. Preparations for the promotion of wound healing in the upper respiratory tract and/or ear
PT1502586E (pt) * 1999-05-27 2007-01-31 Euro Celtique Sa Utilização de anti-sépticos no fabrico de uma preparação farmacêutica para a prevenção ou o tratamento de processos inflamatórios no interior do corpo humano
US7300667B1 (en) * 1999-05-27 2007-11-27 Euro-Celtique, S.A. Preparations for the application of anti-inflammatory, especially antiseptic agents and/or agents promoting the healing of wounds, to the lower respiratory tract
US6497896B2 (en) * 2001-02-12 2002-12-24 Supergen, Inc. Method for administering camptothecins via injection of a pharmaceutical composition comprising microdroplets containing a camptothecin
EP1479379B1 (en) * 2003-05-19 2007-08-29 Euro-Celtique S.A. Dry liposomal PVP-iodine compositions
US8435261B2 (en) * 2009-07-15 2013-05-07 Regents Of The University Of Minnesota Treatment and placement device for sinusitis applications

Also Published As

Publication number Publication date
HK1035336A1 (en) 2001-11-23
IL139229A0 (en) 2001-11-25
DE69933208D1 (de) 2006-10-26
DE29923766U1 (de) 2001-06-07
ES2260915T3 (es) 2006-11-01
HK1035335A1 (en) 2001-11-23
CN1303271A (zh) 2001-07-11
ATE339187T1 (de) 2006-10-15
ES2273493T3 (es) 2007-05-01
CA2332369A1 (en) 1999-12-02
JP2002516269A (ja) 2002-06-04
IL139231A0 (en) 2001-11-25
ATE319427T1 (de) 2006-03-15
EP1083886A1 (en) 2001-03-21
EP1079806A1 (en) 2001-03-07
PT1079806E (pt) 2006-06-30
AU4266799A (en) 1999-12-13
HUP0102892A3 (en) 2002-12-28
HUP0102899A3 (en) 2002-12-28
KR20010043820A (ko) 2001-05-25
WO1999060998A1 (en) 1999-12-02
EP1079807A1 (en) 2001-03-07
CN1303276A (zh) 2001-07-11
CA2332389C (en) 2008-09-09
DK1079806T3 (da) 2006-07-17
PT1079807E (pt) 2007-01-31
KR100613706B1 (ko) 2006-08-21
EP1083886B1 (en) 2003-04-02
CA2332371A1 (en) 1999-12-02
RU2211693C2 (ru) 2003-09-10
AU4370699A (en) 1999-12-13
AU4370499A (en) 1999-12-13
EP1079806B1 (en) 2006-03-08
IL139230A (en) 2007-07-24
BR9911071A (pt) 2001-02-06
US20120009253A1 (en) 2012-01-12
AU747877B2 (en) 2002-05-30
DE29923847U1 (de) 2001-04-12
DE69930259D1 (de) 2006-05-04
IL139230A0 (en) 2001-11-25
DK1079807T3 (da) 2007-01-22
KR20010043821A (ko) 2001-05-25
JP4741726B2 (ja) 2011-08-10
CA2332389A1 (en) 1999-12-02
RU2212884C2 (ru) 2003-09-27
WO1999060999A1 (en) 1999-12-02
HU226729B1 (en) 2009-08-28
JP4741727B2 (ja) 2011-08-10
RU2202340C2 (ru) 2003-04-20
US20080038330A1 (en) 2008-02-14
CY1105834T1 (el) 2011-02-02
EP1079807B1 (en) 2006-09-13
HUP0102337A3 (en) 2002-12-28
AU752018C (en) 2003-10-09
JP2002516266A (ja) 2002-06-04
CN1303272A (zh) 2001-07-11
HUP0102899A2 (hu) 2002-03-28
HU226710B1 (en) 2009-07-28
AU759264B2 (en) 2003-04-10
DE69933208T2 (de) 2007-08-30
ATE235895T1 (de) 2003-04-15
AU752018B2 (en) 2002-09-05
JP2002516265A (ja) 2002-06-04
DE29923848U1 (de) 2001-04-12
WO1999061003A1 (en) 1999-12-02
DE69906518D1 (de) 2003-05-08
BR9911072A (pt) 2001-02-06
DE69930259T2 (de) 2006-11-23
HUP0102337A2 (hu) 2002-03-28
KR20010043819A (ko) 2001-05-25
BR9911070A (pt) 2001-02-06
KR100445146B1 (ko) 2004-08-18

Similar Documents

Publication Publication Date Title
HUP0102892A2 (hu) Erősen tömörített szilárd gyógyszerkészletet tartalmazó hatóanyag-leadó rendszer, eljárás az előállítására és alkalmazására
WO2002024158A3 (en) Pulmonary delivery in treating disorders of the central nervous system
WO2004112702A3 (en) Low dose pharmaceutical powders for inhalation
MY115688A (en) Pharmaceutical composition for administration by inhalation
AU1079701A (en) Oral transmucosal drug dosage using solid solution
SG167657A1 (en) Novel medicament compositions based on tiotropium salts and on salmeterol salts
YU36302A (sh) Novi tiotropiumski preparati - koji sadrže prah za inhaliranje
GEP20002253B (en) Pharmaceutical Aerosol Formulation, Proportioning Inhalator and Method for Treatment of Respiratory Diseases
BR0311701A (pt) Formulação de dosagem multiparticulada com liberação controlada de lamotrigina, composição farmacêutica, processo para a preparação de uma composição farmacêutica de lamotrigina, método para a redução da flutuação no pico e no depósito da concentração da droga no plasma do sangue de um paciente, método para melhorar a complacência de um paciente pela redução da frequência de dosagem para uma vez por dia, método para a ministração mais segura de lamotrigina, método para proporcionar uma concentração terapêutica de plasma de sangue de lamotrigina e uso da formulação
CA2282082A1 (fr) Microgranules contenant du cisplatine
JP2004521950A (ja) Δ８テトラヒドロカンナビノールのエアロゾル製剤
GB2235626B (en) Inhalation medicaments for treating respiratory disorders
SE0303050L (sv) Dosmombinationer
Gonda Targeting by deposition
HK1078795A1 (en) Powder formulations suitable for inhalation
AU3598299A (en) Improved compositions for inhalation
TW200602054A (en) Use of compounds in a dry powder inhaler
SE0302939D0 (sv) Combined doses of formoterol and fluticasone
US20230181847A1 (en) Product delivery devices and methods
SE0303128D0 (sv) Combined doses of formoterol and an anticholinergic agent
CA2516458A1 (en) Use of kahalalide compounds for the manufacture of a medicament for the treatment of psoriasis
ES2184561A1 (es) Forma farmaceutica solida de administracion oral dispersable en agua para el tratamiento de la tuberculosis conteniendo refampicina, isoniazida, pirazinamida y piridoxina hidrocloruro, procedimiento para su obtencion y forma de presentacion de dicha forma farmaceutica.
SE0303375D0 (sv) Combined doses of formoterol and budesonide
HUP9900521A2 (hu) Eljárás nagyon kis dózisú hatóanyagok szilárd dózisformáinak előállítására
JP2004523536A5 (hu)